Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  NuPathe Inc    PATH   US67059M1009

NUPATHE INC (PATH)

3
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancials 
Company
NuPathe Inc. is a biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders.Its primary product, Zecuity (sumatriptan iontophoretic transdermal) for the acute... 
Sector
Pharmaceuticals
Calendar
03/24Earnings Release
More about the company
Chart NUPATHE INC
Duration : Period :
NuPathe Inc Technical Analysis Chart | PATH | US67059M1009 | 4-Traders
Full-screen chart
Latest news on NUPATHE INC
03/05 NUPATHE INC : Teva Completes Tender Offer for NuPathe Inc. Shares
02/26 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Teva Finalizes Tender Offer for NuPath Sh..
02/21 NUPATHE INC : NUPATHE INC. FILES (8-K) Disclosing Termination of a Material Defi..
01/29 NUPATHE INC : Teva Expands CNS Specialty Business with Acquisition of NuPathe
01/26 Analysis - Replay of energetic deal-making seen for drugmakers in 2014
01/21DJU.S. HOT STOCKS : Hot Stocks to Watch
01/21 NUPATHE INC : Endo Merger Agreement with NuPathe Terminated
01/21 NuPathe Terminates Agreement With Endo and Enters Into Agreement to Be Acquir..
More news
Sector news
4h ago Fear factor fades as global M&A hits seven-year high
1d ago AstraZeneca CEO says new Pfizer bid unlikely - Swedish daily DI
2d ago JAZZ PHARMACEUTICALS : Receives FDA Approval For Intravenous Administration Of E..
More sector news


Comments 
Advertisement
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF